Intermediate AMD Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)
Intermediate AMD Market is segmented By Therapy (Iptacopan, Risuteganib, ForeseeHome Monitoring), By Geography (North America, Latin America, Asia Pac....
Intermediate AMD Market Size
Market Size in USD
CAGR5.5%
| Study Period | 2024 - 2031 |
| Base Year of Estimation | 2023 |
| CAGR | 5.5% |
| Market Concentration | Medium |
| Major Players | Alkeus Pharmaceuticals, Apellis Pharmaceuticals, Iveric Bio, Roche, Regeneron Pharmaceuticals |
*Disclaimer: Major players are listed in no particular order.
*Source: Coherent Market Insights
Want to purchase customized report?
please let us know !
please let us know !
Intermediate AMD Market Analysis
The intermediate AMD market is estimated to be valued at USD 1.04 Bn in 2024 and is expected to reach USD 1.52 Bn by 2031, growing at a compound annual growth rate (CAGR) of 5.5% from 2024 to 2031. Rising prevalence of AMD in geriatric population and growing need for effective treatment are expected to remain the top drivers of the intermediate AMD market in the coming years.